Search Results - Franziska Michor

Franziska Michor

Franziska Michor (born 1982) is an Austrian computational biologist. She is a professor in the department of data science at the Dana–Farber Cancer Institute. She serves as Director of the Physical Sciences-Oncology Center and the Center for Cancer Evolution. Provided by Wikipedia
Refine Results
  1. 1

    Patterns of proliferative activity in the colonic crypt determine crypt stability and rates of somatic evolution. by Rui Zhao, Franziska Michor

    Published in PLoS Computational Biology (2013-01-01)
    Get full text
    Article


  2. 2

    (A)symmetric stem cell replication and cancer. by David Dingli, Arne Traulsen, Franziska Michor

    Published in PLoS Computational Biology (2007-03-01)
    Get full text
    Article


  3. 3

    Mathematical modeling identifies optimum lapatinib dosing schedules for the treatment of glioblastoma patients. by Shayna Stein, Rui Zhao, Hiroshi Haeno, Igor Vivanco, Franziska Michor

    Published in PLoS Computational Biology (2018-01-01)
    Get full text
    Article


  4. 4

    Response to: Correspondence on “Early dynamics of clinical and laboratory parameters predict primary refractory disease in patients with metastatic urothelial carcinoma receiving a... by Guru Sonpavde, Paul J Catalano, Franziska Michor, Thomas O McDonald, Christopher Graser

    Published in Journal for ImmunoTherapy of Cancer (2025-06-01)
    Get full text
    Article


  5. 5

    Selection pressure exerted by imatinib therapy leads to disparate outcomes of imatinib discontinuation trials by Min Tang, Jasmine Foo, Mithat Gönen, Joëlle Guilhot, François-Xavier Mahon, Franziska Michor

    Published in Haematologica (2012-10-01)
    Get full text
    Article


  6. 6

    A differentiation-based phylogeny of cancer subtypes. by Markus Riester, Camille Stephan-Otto Attolini, Robert J Downey, Samuel Singer, Franziska Michor

    Published in PLoS Computational Biology (2010-05-01)
    Get full text
    Article


  7. 7

    Early dynamics of clinical and laboratory parameters predict primary refractory disease in patients with metastatic urothelial carcinoma receiving atezolizumab by Guru Sonpavde, Paul J Catalano, Franziska Michor, Christopher J Graser, Thomas O McDonald

    Published in Journal for ImmunoTherapy of Cancer (2025-05-01)
    Get full text
    Article


  8. 8

    Predicting patient outcomes after treatment with immune checkpoint blockade: A review of biomarkers derived from diverse data modalities by Yang Liu, Jennifer Altreuter, Sudheshna Bodapati, Simona Cristea, Cheryl J. Wong, Catherine J. Wu, Franziska Michor

    Published in Cell Genomics (2024-01-01)
    Get full text
    Article


  9. 9

    Distance in cancer gene expression from stem cells predicts patient survival. by Markus Riester, Hua-Jun Wu, Ahmet Zehir, Mithat Gönen, Andre L Moreira, Robert J Downey, Franziska Michor

    Published in PLoS ONE (2017-01-01)
    Get full text
    Article


  10. 10

    Dynamics of chronic myeloid leukemia response to dasatinib, nilotinib, and high-dose imatinib by Adam Olshen, Min Tang, Jorge Cortes, Mithat Gonen, Timothy Hughes, Susan Branford, Alfonso Quintás-Cardama, Franziska Michor

    Published in Haematologica (2014-11-01)
    Get full text
    Article


  11. 11

    The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells by Shannon M. Mumenthaler, Jasmine Foo, Nathan C. Choi, Nicholas Heise, Kevin Leder, David B. Agus, William Pao, Franziska Michor, Parag Mallick

    Published in Cancer Informatics (2015-01-01)
    Get full text
    Article


  12. 12

    Mathematical modeling reveals alternative JAK inhibitor treatment in myeloproliferative neoplasms by Kaitlyn Shank, Andrew Dunbar, Priya Koppikar, Maria Kleppe, Julie Teruya-Feldstein, Isabelle Csete, Neha Bhagwat, Matthew Keller, Outi Kilpivaara, Franziska Michor, Ross L. Levine, Laura de Vargas Roditi

    Published in Haematologica (2020-03-01)
    Get full text
    Article


  13. 13

    Single-cell heterogeneity of EGFR and CDK4 co-amplification is linked to immune infiltration in glioblastoma by Kacper A. Walentynowicz, Dalit Engelhardt, Simona Cristea, Shreya Yadav, Ugoma Onubogu, Roberto Salatino, Melanie Maerken, Cristina Vincentelli, Aashna Jhaveri, Jacob Geisberg, Thomas O. McDonald, Franziska Michor, Michalina Janiszewska

    Published in Cell Reports (2023-03-01)
    Get full text
    Article


  14. 14

    Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity. by Subhajyoti De, Rita Shaknovich, Markus Riester, Olivier Elemento, Huimin Geng, Matthias Kormaksson, Yanwen Jiang, Bruce Woolcock, Nathalie Johnson, Jose M Polo, Leandro Cerchietti, Randy D Gascoyne, Ari Melnick, Franziska Michor

    Published in PLoS Genetics (2013-01-01)
    Get full text
    Article


  15. 15

    Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies. by Kimiyo N Yamamoto, Akira Nakamura, Lin L Liu, Shayna Stein, Angela C Tramontano, Uri Kartoun, Tetsunosuke Shimizu, Yoshihiro Inoue, Mitsuhiro Asakuma, Hiroshi Haeno, Chung Yin Kong, Kazuhisa Uchiyama, Mithat Gonen, Chin Hur, Franziska Michor

    Published in PLoS ONE (2019-01-01)
    Get full text
    Article


  16. 16

    Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis by Debra Van Egeren, Khushi Kohli, Jeremy L. Warner, Philippe L. Bedard, Gregory Riely, Eva Lepisto, Deborah Schrag, Michele LeNoue-Newton, Paul Catalano, Kenneth L. Kehl, Franziska Michor, for the AACR Project GENIE Consortium represented by Shawn Sweeney

    Published in Scientific Reports (2022-11-01)
    Get full text
    Article


  17. 17

    Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses by Siang-Boon Koh, Brian N. Dontchos, Veerle Bossuyt, Christine Edmonds, Simona Cristea, Nsan Melkonjan, Lindsey Mortensen, Annie Ma, Kassidy Beyerlin, Elyssa Denault, Elizabeth Niehoff, Taghreed Hirz, David B. Sykes, Franziska Michor, Michelle Specht, Constance Lehman, Leif W. Ellisen, Laura M. Spring

    Published in npj Precision Oncology (2021-09-01)
    Get full text
    Article


  18. 18

    T-REX17 is a transiently expressed non-coding RNA essential for human endoderm formation by Alexandro Landshammer, Adriano Bolondi, Helene Kretzmer, Christian Much, René Buschow, Alina Rose, Hua-Jun Wu, Sebastian D Mackowiak, Bjoern Braendl, Pay Giesselmann, Rosaria Tornisiello, Krishna Mohan Parsi, Jack Huey, Thorsten Mielke, David Meierhofer, René Maehr, Denes Hnisz, Franziska Michor, John L Rinn, Alexander Meissner

    Published in eLife (2023-01-01)
    Get full text
    Article


  19. 19

    A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) by Arcangelo Liso, Filippo Castiglione, Antonio Cappuccio, Fabrizio Stracci, Richard F. Schlenk, Sergio Amadori, Christian Thiede, Susanne Schnittger, Peter J.M. Valk, Konstanze Döhner, Massimo F. Martelli, Markus Schaich, Jürgen Krauter, Arnold Ganser, Maria P. Martelli, Niccolò Bolli, Bob Löwenberg, Torsten Haferlach, Gerhard Ehninger, Franco Mandelli, Hartmut Döhner, Franziska Michor, Brunangelo Falini

    Published in Haematologica (2008-08-01)
    Get full text
    Article


  20. 20

    A paracrine circuit of IL-1β/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression by Zhihong Chen, Bruno Giotti, Milota Kaluzova, Montse Puigdelloses Vallcorba, Kavita Rawat, Gabrielle Price, Cameron J. Herting, Gonzalo Pinero, Simona Cristea, James L. Ross, James Ackley, Victor Maximov, Frank Szulzewsky, Wes Thomason, Mar Marquez-Ropero, Angelo Angione, Noah Nichols, Nadejda M. Tsankova, Franziska Michor, Dmitry M. Shayakhmetov, David H. Gutmann, Alexander M. Tsankov, Dolores Hambardzumyan

    Published in The Journal of Clinical Investigation (2023-11-01)
    Get full text
    Article


Search Tools: